OTORHINOLARYNGOLOGICAL PHARMACEUTICAL PREPARATIONS

Brand Owner (click to sort) Address Description
OPATANASE NOVARTIS AG CH-4002 Basel 4002 Switzerland Otorhinolaryngological pharmaceutical preparations for the treatment of allergies;
OPATANASE ALCON, INC. Bösch 69 CH-6331 Hünenberg Switzerland Otorhinolaryngological pharmaceutical preparations;
OPATANASE NOVARTIS AG CH-4002 Basel 4002 Switzerland Otorhinolaryngological pharmaceutical preparations for the treatment of allergies;
PATANASE NOVARTIS AG CH-4002 Basel 4002 Switzerland Otorhinolaryngological pharmaceutical preparations;
PATANASE NOVARTIS AG CH-4002 Basel 4002 Switzerland otorhinolaryngological pharmaceutical preparations;Color is not claimed as a feature of the mark.;
PATANEX NOVARTIS AG CH-4002 Basel 4002 Switzerland Otorhinolaryngological pharmaceutical preparations for the treatment of allergies;The wording PATANEX has no meaning in a foreign language.;
PATANEX ALCON, INC. Bösch 69 CH-6331 Hünenberg Switzerland Otorhinolaryngological pharmaceutical preparations;
PATANEX NOVARTIS AG CH-4002 Basel 4002 Switzerland Otorhinolaryngological pharmaceutical preparations for the treatment of allergies;The wording PATANEX has no meaning in a foreign language.;
SOFENZ ALCON UNIVERSAL LTD. Bosch 69 CH-6331 Hunenberg Switzerland Otorhinolaryngological pharmaceutical preparations;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.